Printer Friendly

Browse Ciprofloxacin topic

Subtopics (23)



1-143 out of 143 article(s)
Title Author Type Date Words
Pheniramine maleate inj 22.75 mg/ml 2 ml amp, amikacin sulphate 500 mg inj, amoxycillin 1000 mg clavulanic acid 200 mg inj, ciprofloxacin 100 mg/50 ml iv inj 100 ml. Mar 24, 2015 109
Inj. ciprofloxacin 2 mg/ml 100 ml. Mar 23, 2015 101
Tab. ciprofloxacin 250 mg. Mar 19, 2015 179
Tab. ciprofloxacin 500 mg (strip pack). Mar 18, 2015 105
Ciprofloxacin 500 mg tab in strip. Mar 14, 2015 479
Supply of Amoxycillin Trihydrate-Ip-Compacted, Ampicillin Trihydrate-Ip-Compacted, Doxycyline Hydrochloride-Ip, Fluconazole-Ip, Ciprofloxacin-Hydrochloride-Ip, Cephelexin Monohydrate-Ip, Nimesulide-Bp. Feb 28, 2015 157
Inj. ciprofloxacin 2 mg/ml 100 ml. Feb 25, 2015 103
Injection ciprofloxacin 200 mg / 100 ml bottle. Jan 13, 2015 129
FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation. Nov 24, 2014 738
Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant clone, Spain. Ardanuy, Carmen; de la Campa, Adela G.; Garcia, Ernesto; Fenoll, Asuncion; Calatayud, Laura; Cercena Report Nov 1, 2014 5233
Supply of medicines : xylometazoline 0.1% nasal drops/spray, TAB.Diosmin 500 MG, Ciprofloxacin 0.30% EYE DROPS, TAB.Amitryptyline 25 MG. Oct 14, 2014 127
SALVAT Announces Positive Top-line Results from Two Phase III Studies of its Novel Otic Antibiotic/Steroid Combination Solution in the Treatment of AOMT with Tympanostomy Tubes. Sep 29, 2014 841
SALVAT Announces Positive Top-line Results from Two Phase III Studies of its Novel Otic Antibiotic/Steroid Combination Solution in the Treatment of AOMT with Tympanostomy Tubes. Sep 29, 2014 843
National sentinel site surveillance for antimicrobial resistance in Klebsiella pneumoniae isolates in South Africa, 2010-2012. Perovic, O.; Singh-Moodley, A.; Duse, A.; Bamford, C.; Elliott, G.; Swe-Han, K. Swe; Kularatne, R.; Report Aug 1, 2014 4765
Supply Of Ciprofloxacin 0.30% Eye Drops, Tab.Allopurinol 100 Mg, Inj.Isophane Insulin 70 % + Insulin Biphasic 30. Jul 26, 2014 114
Supply of: sulphacetamide sod. Eye drop-10ml,supply of : ciprofloxacin eye drop- 0.30%-5ml,supply of : ofloxacin eye drop-0.30%- 5ml. Jul 7, 2014 118
Supply Of Medicine (Ear drop- parachlorbenzene + benzocaine -2%+2%, eye ointment- Ciprofloxacin-0.30%, - eye drop- Olopatadine-1%, eye drop- Hydroxypropyle methyle cellulose 0.5%, eye drop- corboxy Me. Jul 1, 2014 139
Procurement of medicines (Tab.Albendazole 400 Mg, Albendazole Suspension 200 Mg/5 Ml, Ciprofloxacin I.V.100 Ml, Tab.Diclofenac 50 Mg, Tab.Acetaminophen(Paracetamol) 500 Mg, Tab.Aceclofenac 100 Mg +Par. Jun 21, 2014 168
Supply Of Chlorphenaramine Maleate:(Phenylephrine + Naphazoline +Menthol,Camphor And Cpm) Eye Drops 10 Ml/.2)Ciprofloxacin + Dexamethasone Eye/Ear Drops 10 Ml.3)Losartan 50 Mg + Amlodipine 5 Mg Tab.Et. Jun 2, 2014 123
Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis. Rudzinski, Jan Krzysztof; Kawakami, Jun Report May 1, 2014 3847
Ciprofloxacin-resistant Salmonella enterica serotype Kentucky sequence type 198. Rickert-Hartman, Regan; Folster, Jason P. Letter to the editor May 1, 2014 954
Germany : FDA Grants Orphan Drug Designation for Bayer s Investigational Ciprofloxacin Dry Powder for Inhalation for Treatment of NCFB. Apr 23, 2014 423
FDA Grants Orphan Drug Designation for Bayer's Investigational Ciprofloxacin DPI (Dry Powder for Inhalation) for Treatment of Non-Cystic Fibrosis Bronchiectasis. Apr 22, 2014 658
Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006. Chesson, Harrell W.; Kirkcaldy, Robert D.; Gift, Thomas L.; Owusu-Edusei, Kwame, Jr.; Weinstock, Hil Apr 1, 2014 5598
Salmonella subtypes with increased MICs for azithromycin in travelers returned to the Netherlands. Hassing, Robert-Jan; Goessens, Wil H.F.; van Pelt, Wilfrid; Mevius, Dik J.; Stricker, Bruno H.; Molh Report Apr 1, 2014 2375
Susceptibility testing of extended-spectrum-[beta]-lactamase (ESBL)-producing enterobacteriaceae against oral antimicrobials, including fosfomycin and mecillinam. Creighton, Julie A. Report Apr 1, 2014 3925
Antibiotic resistance in thermotolerant campylobacter isolated in 2000/01 and 2010 from patients with diarrhoea in Dunedin, New Zealand. Harrington, Michael G.; Lopes, Rebecca M.; Hughes, Kimberley A.; Weaver, Julie E.; Parslow, Gayleen; Report Apr 1, 2014 3218
Frame according to one batch operator to supply the medication pantoprazole (doe) parenteral, ciprofloxacin (doe), clindamycin (doe) parenteral, acetylcysteine ??(doe) and eculizumab parenteral (doe). Mar 25, 2014 134
Tab. ciprofloxacin-500 mg. mfg:-torrent,. Mar 24, 2014 133
Supply of medicines - tab ciprofloxacin 500mg etc. Mar 3, 2014 108
[beta]-Lapachone activity in synergy with conventional antimicrobials against methicillin resistant Staphylococcus aureus strains. Macedo, L.; Fernandes, T.; Silveira, L.; Mesquita, A.; Franchitti, A.A.; Ximenes, E.A. Report Dec 15, 2013 4957
Assessment of the diversity and antibiotic susceptibility of Salmonella spp. isolated from food and human patients with gastroenteritis. Boukoucha, Mourad; Ramdani-Bouguessa, Nadjia; Menasria, Taha; Bouguerra, Nadia Nov 1, 2013 5176
Ciprofloxacin-resistant Campylobacter spp. in retail chicken, Western Canada. Agunos, Agnes; Leger, David; Avery, Brent P.; Parmley, E. Jane; Deckert, Anne; Carson, Carolee A.; D Jul 1, 2013 2510
Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in gauteng province, south Africa. Lewis, D.A.; Gumede, L.Y.E.; van der Hoven, L.A.; de Gita, G.N.; de Kock, E.J.E.; de Lange, T.; Mase Report Jun 1, 2013 4775
Ciprofloxacin-resistant Salmonella enterica serovar Kentucky in Canada. Mulvey, Michael R.; Boyd, David A.; Finley, Rita; Fakharuddin, Ken; Langner, Stacie; Allen, Vanessa; Jun 1, 2013 1791
Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010-2011. Gaudreau, Christiane; Helferty, Melissa; Sylvestre, Jean-Loup; Allard, Robert; Pilon, Pierre A.; Poi May 1, 2013 2372
Culture, identification and susceptibility testing of Clostridium difficile from EIA toxin positive faecal samples. Stevens, Mary Apr 1, 2013 1917
Comparative pharmacokinetics of enrofloxacin, danofloxacin, and marbofloxacin after intravenous and oral administration in Japanese quail (Coturnix coturnix japonica). Haritova, Aneliya; Dimitrova, Dimitrichka; Dinev, Toncho; Moutafchieva, Rumyana; Lashev, Lubomir Report Mar 1, 2013 5860
Aradigm Announces Private Placement for $6 Million. Dec 12, 2012 815
UK Scientists Report on Efficacy of Aradigm's Lipoquin[TM] Against Pneumonic Plague. Nov 19, 2012 1153
Virginia Commonwealth University Scientists Report Anti-Inflammatory Effect of Aradigm's Inhaled Liposomal Ciprofloxacin. Oct 16, 2012 934
Common antibiotic boosts spread of deadly superbug. Sep 21, 2012 386
UK Scientists Report Successful Testing of Aradigm's Inhaled Liposomal Ciprofloxacin in Q Fever. Sep 20, 2012 887
New U.S. Composition of Matter Patent for Aradigm's Pulmaquin[TM] and Lipoquin[TM] Provides Protection Until 2031. Sep 18, 2012 797
Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States. Goldstein, Edward; Kirkcaldy, Robert D.; Reshef, David; Berman, Stuart; Weinstock, Hillard; Sabeti, Aug 1, 2012 5452
Northeastern Section of the American Urological Association 64th Annual Meeting, Niagara Falls, Ontario Scientific Program. Rowe, Neal E.; Breau, Rodney H.; Cagiannos, Ilias; Zvonar, Rosemary; Fergusson, Dean; Lavallee, Luke Aug 1, 2012 10228
Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection bacteria and their synergistic potential with antibiotics. Fadli, Mariam; Saad, Asmaa; Sayadi, Sami; Chevalier, Jacqueline; Mezrioui, Nour-Eddine; Pages, Jean- Report May 1, 2012 7123
Aradigm Receives U.S. FDA Clearance for Phase 3 Clinical Trial of Pulmaquin[TM] in Patients with Non-Cystic Fibrosis Bronchiectasis. Mar 12, 2012 726
Is there an ototoxicity risk from cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings. Berenholz, Leonard P.; Rossi, Dyana L.; Lippy, William H.; Burkey, John M. Report Mar 1, 2012 3277
Synergistic activity of coriander oil and conventional antibiotics against acinetobacter baumannii. Duarte, A; Ferreira, S.; Silva, F.; Domingues, F.C. Report Mar 1, 2012 2157
US Patent Protection for Pulmaquin[TM] Is Extended with Issuance of a Composition of Matter Patent. Feb 21, 2012 831
Aradigm Selects Pulmaquin[TM] for Phase 3 Development and Announces Issuance of Its First U.S. Patent Covering Inhaled Ciprofloxacin Formulations. Dec 7, 2011 847
Meningococcal infections in hospitalised patients in Pretoria. Moodley, T.; Lekalakala, M.R.; de Gouveia, L.; Dangor, Y.; Hoosen, A.A. Report Oct 1, 2011 1286
Bacteremia and antimicrobial drug resistance over time, Ghana. Gross, Uwe; Amuzu, Sylvarius K.; de Ciman, Ring; Kassimova, Iparkhan; Gross, Lisa; Rabsch, Wolfgang; Oct 1, 2011 2501
Aradigm Presents Additional Analyses of the Clinical Results From ORBIT-1 and ORBIT-2 Trials of Inhaled Ciprofloxacin at the 2011 European Respiratory Society (ERS) Annual Congress. Sep 21, 2011 799
Aradigm Announces Private Placement for $4.75 Million. Jul 6, 2011 965
Ciprofloxacin in critically ill children. Sideri, G.; Kafetzis, D.A.; Vouloumanou, E.K.; Papadatos, J.H.; Papadimitriou, M.; Falagas, M.E. Clinical report Jul 1, 2011 2720
Assessing the role of proper administration of antibiotics in the treatment of corneal ulcers in dog. Asghari, Ahmad; Gharachorlou, Aliasghar Report Jul 1, 2011 1421
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin. Jun 16, 2011 1239
Aradigm Receives FDA Orphan Drug Designation for Ciprofloxacin for Inhalation in Bronchiectasis. Jun 6, 2011 864
Methicillin-resistant Staphylococcus aureus, Samoa, 2007-2008. Alesana-Slater, James; Ritchie, Stephen R.; Heffernan, Helen; Camp, Tracy; Richardson, Alice; Herbis Jun 1, 2011 5371
Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. Taneja, Neelam; Singh, Gagandeep; Singh, Meenakshi; Sharma, Meera Report Jun 1, 2011 2286
Increasing ceftriaxone resistance in Salmonellae, Taiwan. Su, Lin-Hui; Teng, Wen-Shin; Chen, Chyi-Liang; Lee, Hao-Yuan; Li, Hsin-Chieh; Wu, Tsu-Lan; Chiu, Che Jun 1, 2011 3094
Salmonella enterica serotype Typhi with nonclassical quinolone resistance phenotype. Accou-Demartin, Marie; Gaborieau, Valerie; Song, Yajun; Roumagnac, Philippe; Marchou, Bruno; Achtman Jun 1, 2011 2646
Ciprofloxacin-resistant Salmonella enterica serotype Typhi, United States, 1999-2008. Medalla, Felicita; Sjolund-Karlsson, Maria; Shin, Sanghyuk; Harvey, Emily; Joyce, Kevin; Theobald, L Report Jun 1, 2011 3412
Malignant otitis externa with skull base osteomyelitis. Case study May 14, 2011 1239
Tools for tracking antibiotic resistance. Report May 1, 2011 4311
Rapid situation & response assessment of diarrhoea outbreak in a coastal district following tropical cyclone AILA in India. Panda, Samiran; Pati, Kamala Kanta; Bhattacharya, Mihir Kumar; Koley, Hemanta; Pahari, Sobha; Nair, Report Apr 1, 2011 3789
Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa. Bhattacharya, S.S.; Das, Usha; Choudhury, B.K. Clinical report Apr 1, 2011 1620
Aradigm Completes Enrollment in Phase 2b Study of Inhaled Ciprofloxacin for the Management of Respiratory Infections in Bronchiectasis. Mar 22, 2011 1005
Aradigm to Report Expanded Results from Successful Six-Month Phase 2b Bronchiectasis Study at Biotech Showcase 2011. Jan 6, 2011 1088
Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections. Al-Mashhadani, Manar; Hewson, Robert; Vivancos, Roberto; Keenan, Alex; Beeching, Nick J.; Wain, John Jan 1, 2011 2188
Aradigm Awarded Three Therapeutic Discovery Tax Credit Grants Totaling Over $733,000 for Inhaled Liposomal Ciprofloxacin Program. Nov 2, 2010 937
Plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica Isolates, USA. Sjolund-Karlsson, Maria; Howie, Rebecca; Rickert, Regan; Krueger, Amy; Tran, Thu-Thuy; Zhao, Shaohua Nov 1, 2010 2106
Vibrio cholerae 01 variant with reduced susceptibility to ciprofloxacin, Western Africa. Quilici, Marie-Laure; Massenet, Denis; Gake, Bouba; Bwalki, Barem; Olson, David M. Letter to the editor Nov 1, 2010 1151
Aradigm Reports Successful Phase 2b Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin. Oct 20, 2010 1370
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress. Sep 17, 2010 772
Tumour necrosis factor neutralization in MS: a cautionary tale. Arnason, B.G.W. Clinical report Jul 1, 2010 4177
Aradigm Announces Private Placement for $5 Million. Jun 21, 2010 999
Aradigm Presents at the 2010 International Conference of the American Thoracic Society. Conference news May 17, 2010 665
Aradigm Receives FDA Clearance for Clinical Trial of Inhaled Liposomal Ciprofloxacin in Pediatric Patients With Cystic Fibrosis. May 5, 2010 903
Aradigm Completes Enrollment and Doses Last Patient in Long Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. Mar 25, 2010 735
Aradigm Doses First Patient in Its Second Phase 2b Clinical Trial of Inhaled Liposomal Ciprofloxacin in Bronchiectasis Patients. Feb 23, 2010 842
Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications. Tanih, Nicoline F.; Okeleye, Benjamin I.; Naidoo, Nathan; Clarke, Anna M.; Mkwetshana, Noxolo; Green Report Jan 1, 2010 2755
Necrotizing otitis externa: a new trend? Report of 6 atypical cases. Glynn, Fergal; Walsh, Rory McConn Case study Dec 1, 2009 2029
Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. Nov 16, 2009 696
Imported ciprofloxacin-resistant Neisseria meningitidis. Lapadula, Giuseppe; Vigano, Franco; Fortuna, Paolo; Dolara, Alberto; Bramati, Simone; Soria, Alessan Report Nov 1, 2009 1156
Aradigm Presents Data Demonstrating Significant Antibacterial Concentrations and Effects in Non-Cystic Fibrosis Bronchiectasis Patients Following Administration of its Once-Daily Inhaled Liposomal Ciprofloxacin. Sep 14, 2009 528
Ciprofloxacin: a novel therapeutic agent for iron overload?/ Siprofloksasin: demir yuklenmesi icin yeni bir terapotik ajan mi? Elmi, Mitra; Rahimi-Moghaddam, Parvaneh; Abdi, Khosrou; Shafiee-Ardestani, Mehdi; Mahmoudian, Massou Clinical report Sep 1, 2009 2119
Aradigm Receives Orphan Drug Designation for Inhaled Liposomal Ciprofloxacin to Treat Cystic Fibrosis in Europe. Aug 5, 2009 576
Aradigm Receives FDA Clearance for Phase IIb Clinical Trial of Inhaled Liposomal Ciprofloxacin to Treat Bronchiectasis. Jul 23, 2009 782
Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL[R] (ciprofloxacin otic solution) 0.2%. Jul 8, 2009 456
Aradigm Presents Phase 1 and Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients at the 32nd European Cystic Fibrosis Conference. Conference news Jun 11, 2009 521
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. de la Campa, Adela G.; Ardanuy, Carmen; Balsalobre, Luz; Perez-Trallero, Emilio; Marimon, Jose M.; F Jun 1, 2009 5508
Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis at 2009 International Conference of the American Thoracic Society. Conference news May 14, 2009 628
Aradigm Reports Positive Phase 2 Results with Inhaled Liposomal Ciprofloxacin Hydrochloride in Patients with Bronchiectasis. Financial report Jan 21, 2009 1062
Molecular epidemiological characteristics of Shigella spp. isolated from river Narmada during 2005-2006. Sharma, Anjana; Singh, Susheel Kumar; Kori, Lokesh Report Jan 1, 2009 3937
An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh. Gupta, Varsha; Kaur, Jaspal; Chander, Jagdish Report Jan 1, 2009 2327
Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%. Dec 12, 2008 545
Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis at the North American Cystic Fibrosis Conference. Conference news Oct 23, 2008 640
Aradigm Completes Enrollment in Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Bronchiectasis. Oct 14, 2008 416
Serogroup a Neisseria meningitidis with reduced susceptibility to ciprofloxacin. Strahilevitz, Jacob; Adler, Amos; Smollan, Gillian; Temper, Violeta; Keller, Nathan; Block, Colin Clinical report Oct 1, 2008 1268
Ciprofloxacin resistance in Neisseria meningitidis, France. Skoczynska, Anna; Alonso, Jean-Michel; Taha, Muhamed-Kheir Aug 1, 2008 1136
Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe. Jul 23, 2008 978
Aradigm Reports Successful Top-line Phase 2 Data with Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis. Clinical report Jun 30, 2008 695
Alternatives to ciprofloxacin use for enteric fever, United Kingdom. Threlfall, E. John; de Pinna, Elizabeth; Day, Martin; Lawrence, Joanne; Jones, Jane Letter to the editor May 1, 2008 1177
Integrated food chain surveillance system for Salmonella spp. in Mexico (1). Zaidi, Mussaret B.; Calva, Juan Jose; Estrada-Garcia, Maria Teresa; Leon, Veronica; Vazquez, Gabriel Mar 1, 2008 5131
Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China. Shenghui, Cui; Jingyun, Li; Ziyong, Sun; Changqin, Hu; Shaohong, Jin; Yunchang, Guo; Lu, Ran; Yue, M Mar 1, 2008 2008
Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Hopkins, Katie L.; Day, Martin; Threlfall, E. John Letter to the editor Feb 1, 2008 1720
Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis. Nov 19, 2007 633
Bacterial resistance to quinolone otic drops is nearly zero. Poole, Michael D. Nov 1, 2007 1299
Relative value of different fluoroquinolones. Gall, Richard M. Nov 1, 2007 947
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field. Sep 25, 2007 802
Optimer Presents Positive Data on Two Lead Anti-Infective Drug Candidates. Sep 20, 2007 602
Tizanidine contraindicated for use with Luvox, Cipro. Mechcatie, Elizabeth Aug 1, 2007 385
Depomed Enters into Promotion Agreement with Watson for ProQuin(R) XR. Jul 23, 2007 790
Depomed Reacquires the Rights to ProQuin(R) XR. Jul 5, 2007 661
Community-acquired extended-spectrum [beta]-lactamase producers, United States. Paterson, David L. Letter to the editor Jul 1, 2007 1282
Bioequivalence and pharmacokinetic study of two oral formulations of ciprofloxacin tablets in healthy male volunteers. Kalam Azad, Mohammad Abul; Ullah, Ashik; Mahbub, A.H.M.; Hasnat, Abul Clinical report Jun 1, 2007 4604
Depomed Reports 2006 Year End Financial Results. Financial report Mar 14, 2007 901
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis. Jan 16, 2007 559
FDA approves first generic ciprofloxacin injection, USP. Oct 1, 2006 216
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? Goldner, Bruce Jan 1, 2006 3917
Single drug dose may be better against cholera. Brief Article Oct 29, 2005 274
The effect of natural sunlight on ciprofloxacin ophthalmic solution (1). Das, Subodh C. Oct 1, 2005 2533
Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. Wu, Jiunn-Jong Jun 1, 2005 2809
Bacterial meningitis. Worcester, Sharon Brief Article Mar 1, 2005 120
Resistant campylobacter. Worcester, Sharon Brief Article Oct 15, 2003 150
Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. (Dispatches). Kotilainen, Pirkko Feb 1, 2003 2160
Antibiotics and Crohn's disease. (Clinical Capsules). Evans, Jeff Brief Article Aug 15, 2002 148
Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. (Research). George, Robert C. May 1, 2002 4294
The real Bayer fallout. (Market Horizons). Richter, Stephan Brief Article Feb 1, 2002 675
A reminder-Cipro & Running. Brief Article Jan 1, 2002 288
Internet ciprofloxacin. (Clinical Capsules). Worcester, Sharon Dec 15, 2001 172
MED7 Ciprofloxacin immune hemolytic anemia. (Medicine). Brief Article Dec 1, 2001 295
Reduced fluoroquinolone susceptibility in salmonella enterica serotypes in travelers returning from Southeast Asia. (Research). Siitonen, Anja Statistical Data Included Nov 1, 2001 5708
Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. (Research). Endtz, Hubert Statistical Data Included Sep 1, 2001 6902
Decreased Susceptibility to Ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Ward, Linda R. May 1, 2001 2236
High-Level Ciprofloxacin Resistance in Neisseria gonorrhoeae: First Report from Israel. Sheinberg, Bracha Jan 1, 2001 962
Antibiotics and athletic injury--warning. Brief Article Feb 1, 2000 220
Bacterial Resistance to Ciprofloxacin in Greece: Results from the National Electronic Surveillance System. Legakis, N.J. May 1, 1999 3510
Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection. Kamberi, Marika; Tsutsumi, Kimiko; Kotegawa, Tsutomu; Nakamura, Koichi; Nakano, Shigeyuki Jun 1, 1998 2286
Drug side effect of java jitters? Edwards, Diane D. Oct 17, 1987 217

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters